Archive · 24 Jun 2025
Rubicon Acquires Alkem Manufacturing Unit for Expansion
A company called Rubicon bought a factory from Alkem for about $18 million.
This factory in India makes medicines like steroids.
Rubicon wants to make more products to sell in the United States.
Rubicon is doing well and growing fast in the medicine business, and it plans to offer shares to the public soon.
Rubicon Research Limited acquired Alkem Laboratories' Pithampur manufacturing unit for Rs. 149 crores.
The facility in Madhya Pradesh manufactures steroids, hormones, and high-potency products.
The acquisition expands Rubicon's manufacturing capabilities and strengthens its supply chain.
Rubicon is focused on regulated markets, especially the US, with 69 FDA-approved products.
Rubicon's revenue has more than doubled, making it the fastest-growing Indian pharmaceutical formulations company among its peers.
- Who
- Rubicon Research Limited and Alkem Laboratories
- What
- Rubicon Research Limited acquired Alkem Laboratories' manufacturing unit.
- When
- June 24
- Where
- Pithampur, Madhya Pradesh, India
- Why
- To expand manufacturing capabilities and strengthen market presence.
- Acquisition Price
- Rs. 149 crores
- Facility Location
- Pithampur, Madhya Pradesh, India
- Facility Products
- Steroids, hormones, and high-potency products
- US FDA Inspection
- 2022
- Rubicon's Revenue Growth (Fiscal 2022-2024)
- CAGR of 62.5%
- US FDA Approved Products (Rubicon)
- 69